• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

04/24/2019/by CAPTIS

Lilly’s Taltz meets primary endpoint in phase 3 nr-axSpA trial

Taltz met the primary and all key secondary endpoints in the…
04/24/2019/by CAPTIS

Lilly announces sale of legacy antibiotics brands and manufacturing facility in China

04/24/2019/by CAPTIS

FSD Pharma to acquire Prismic Pharmaceuticals

04/23/2019/by CAPTIS

Fulcrum acquires global rights of investigational drug losmapimod from GSK

04/23/2019/by CAPTIS

Teva launches generic version of VESIcare (solifenacin succinate) tablets in US

04/23/2019/by CAPTIS

FDA approves Merck’s Keytruda plus Inlyta to treat advanced renal cell carcinoma

04/23/2019/by CAPTIS

Forbius announces first patient dosed in phase 2a EGFR-overexpressing TNBC trial of AVID100

04/22/2019/by CAPTIS

Viela Bio receives US FDA breakthrough therapy designation for Inebilizumab to treat Neuromyelitis Optica Spectrum Disorder

04/22/2019/by CAPTIS

AqVida, Phyton receive approval from EDQM for AqVida’s paclitaxel injectable FDF

04/22/2019/by CAPTIS

Pfizer, Lilly’s painkiller tanezumab shows mixed results in phase 3 osteoarthritis trial

04/18/2019/by CAPTIS

CASI Pharmaceuticals in-licenses rights to novel anti-CD38 monoclonal antibody program from Black Belt Therapeutics

Under the terms of the agreement, CASI has obtained global rights…
04/18/2019/by CAPTIS

SK Biopharmaceuticals, twoXAR collaborate to develop treatments for NSCLC

04/18/2019/by CAPTIS

FDA approves DUAKLIR PRESSAIR to treat chronic obstructive pulmonary disease

04/18/2019/by CAPTIS

LabCorp to buy Envigo’s non-clinical research services business in $485m deal

04/17/2019/by CAPTIS

DNDi, Atomwise collaborate to advance drug development using AI for neglected diseases

04/17/2019/by CAPTIS

MS Pharma to acquire European pharmaceutical firm Genepharm

04/17/2019/by CAPTIS

FDA grants orphan drug designation to NeoImmuneTech’s Hyleukin-7 for idiopathic CD4+ lymphocytopenia treatment

04/17/2019/by CAPTIS

Gilead, insitro collaborate to develop therapies for nonalcoholic steatohepatitis

04/16/2019/by CAPTIS

FDA accepts Novartis’s BLA for brolucizumab for treatment of wet AMD

04/16/2019/by CAPTIS

Egypt fast-track medical device registration pathway speeds up market access timeframes

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

We Suggest:

Allele, SCM Lifescience sign joint research and development agreement to develop iPSC-based diabetes treatment

0 Comments
/
04/16/2019
iPSCs can be derived from adult human tissue cells yet share…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-16 01:01:262019-04-16 01:01:27Allele, SCM Lifescience sign joint research and development agreement to develop iPSC-based diabetes treatment

Alnylam initiates ILLUMINATE-B phase 3 pediatric study of Lumasiran to treat primary hyperoxaluria type 1

0 Comments
/
04/16/2019
The study will enroll approximately eight patients with PH1 under…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-16 01:01:232019-04-16 01:01:24Alnylam initiates ILLUMINATE-B phase 3 pediatric study of Lumasiran to treat primary hyperoxaluria type 1

Catalent to buy CDMO Paragon Bioservices for $1.2bn

0 Comments
/
04/16/2019
Paragon Bioservices is a major viral vector development and manufacturing…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-16 00:01:592019-04-16 00:02:00Catalent to buy CDMO Paragon Bioservices for $1.2bn

Glaukos touts 5-year study of glaucoma stents

0 Comments
/
04/15/2019
Glaukos  (NYSE:GKOS) said today that a study of its iStent…
Read more
https://www.captis.com/wp-content/uploads/2019/04/Glaukosupdated-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 11:52:012019-04-15 12:01:14Glaukos touts 5-year study of glaucoma stents

More device shortages pegged to sterilization plant shutdown

0 Comments
/
04/15/2019
Cardinal Health’s Accu-Trace intrauterine pressure catheter…
Read more
https://www.captis.com/wp-content/uploads/2019/04/CardinalHealthAccu-Traceintrauterinepressurecatheter-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 10:19:012019-04-15 10:31:23More device shortages pegged to sterilization plant shutdown

Penumbra VR device wins FDA clearance

0 Comments
/
04/15/2019
Penumbra recently announced that it has received FDA 510(k)…
Read more
https://www.captis.com/wp-content/uploads/2019/04/penumbra-logo-300x195.png 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 09:24:562019-04-15 09:31:12Penumbra VR device wins FDA clearance

Corindus touts first Japanese CorPath GRX procedures

0 Comments
/
04/15/2019
Corindus Vascular Robotics (NYSE:CVRS) said today that the…
Read more
https://www.captis.com/wp-content/uploads/2019/04/corindus-7x4-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 07:10:122019-04-15 07:32:13Corindus touts first Japanese CorPath GRX procedures

FDA approves Intact Vascular’s Tack dissection repair device

0 Comments
/
04/15/2019
The FDA last week granted pre-market approval to the Tack endovascular…
Read more
https://www.captis.com/wp-content/uploads/2019/04/intact-vascular-7x4-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 06:29:322019-04-15 06:31:29FDA approves Intact Vascular’s Tack dissection repair device

FDA clears Gelesis weight-loss hydrogel pill Plenity

0 Comments
/
04/15/2019
  [Image from Gelesis]Gelesis (Boston) recently announced…
Read more
https://www.captis.com/wp-content/uploads/2019/04/plenity-gelesis-300x200.jpg 200 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 06:19:392019-04-15 06:31:26FDA clears Gelesis weight-loss hydrogel pill Plenity

U.K. government requests Brexit deadline extension

0 Comments
/
04/15/2019
By Ronald Boumans, Emergo Group The U.K. government has requested…
Read more
https://www.captis.com/wp-content/uploads/2019/04/emergo-1x1-6.jpg 150 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 03:00:472019-04-15 03:01:34U.K. government requests Brexit deadline extension

Dr. Reddy’s Laboratories announces acquisition of ANDA portfolio

0 Comments
/
04/15/2019
The portfolio includes more than 30 generic injectable products.…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 02:31:242019-04-15 02:31:25Dr. Reddy’s Laboratories announces acquisition of ANDA portfolio

Gilead Sciences and Novo Nordisk announce intent to initiate a clinical collaboration in NASH

0 Comments
/
04/15/2019
The intended clinical trial will be a proof-of-concept study…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 02:31:212019-04-15 02:31:22Gilead Sciences and Novo Nordisk announce intent to initiate a clinical collaboration in NASH

AAV gene therapy company AskBio secures $235m investment

0 Comments
/
04/15/2019
The investment in AskBio includes an amount of $225m committed…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 02:01:182019-04-15 02:01:19AAV gene therapy company AskBio secures $235m investment

Janssen’s Balversa gets FDA approval for metastatic bladder cancer

0 Comments
/
04/15/2019
Balversa is now indicated in the US for the treatment of adult…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-15 00:02:152019-04-15 00:02:17Janssen’s Balversa gets FDA approval for metastatic bladder cancer

EO plant shutdown leads to pediatric breathing tube shortage

0 Comments
/
04/12/2019
Smiths Medical Bivona tracheostomy tubes are in short supply,…
Read more
https://www.captis.com/wp-content/uploads/2019/04/smiths-medical-bivona_flextend-tracheostemy-tubes-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-12 13:44:092019-04-12 14:01:30EO plant shutdown leads to pediatric breathing tube shortage

NuVasive launches X360 lateral single-position surgery device

0 Comments
/
04/12/2019
NuVasive Inc. (NSDQ:NUVA) said yesterday that it launched…
Read more
https://www.captis.com/wp-content/uploads/2019/04/nuvasive-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-12 12:59:172019-04-12 13:01:32NuVasive launches X360 lateral single-position surgery device

Stryker wins FDA PMA, launches Lifepak CR2 AED

0 Comments
/
04/12/2019
Stryker (NYSE:SYK) said yesterday that it launched its…
Read more
https://www.captis.com/wp-content/uploads/2019/04/stryker-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-12 12:34:092019-04-12 13:01:28Stryker wins FDA PMA, launches Lifepak CR2 AED

TissueTech raises $55m

0 Comments
/
04/12/2019
TissueTech has raised approximately $55.3 million in a new round…
Read more
https://www.captis.com/wp-content/uploads/2019/04/tissuetech-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-12 12:13:352019-04-12 12:31:41TissueTech raises $55m

FDA clears moldable OssiMend bioactive bone graft from Collagen Matrix

0 Comments
/
04/12/2019
Collagen Matrix said today that it won FDA 510(k) clearance…
Read more
https://www.captis.com/wp-content/uploads/2019/04/collagen-matrix-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-12 11:35:352019-04-12 12:02:25FDA clears moldable OssiMend bioactive bone graft from Collagen Matrix

Philips to private-label Demant hearing aids

0 Comments
/
04/12/2019
William Demant (CPH:WDH) said this week that it inked a…
Read more
https://www.captis.com/wp-content/uploads/2019/04/demant-philips-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-04-12 11:07:042019-04-12 11:31:20Philips to private-label Demant hearing aids
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
CAPTIS
CAPTIS
@CaptisCorp

Let's meet at #AAOS2019 in Las Vegas. Feel free to make contact. pic.twitter.com/Cybu…

reply retweet favorite
4:11 pm · 03/14/2019
Twitter
Dr. Alfredo Figueiredo
Dr. Alfredo Figueiredo
@AlfredoFig1

#LowBackPain - a good summary by the European Spine Society @EUROSPINESoc eurospinepatientline… #Orthopaedics #SpineSurgery pic.twitter.com/yo6E…

reply retweet favorite
5:05 am · 02/21/2019 ·
Retweeted by CAPTIS
Twitter
CAPTIS
CAPTIS
@CaptisCorp

Happy President's Day from CAPTIS!

reply retweet favorite
5:06 pm · 02/18/2019
Twitter
Medtronic Spine
Medtronic Spine
@Medtronic_Spine

We are saddened to share the news of the passing of Dr. Yves Cotrel. A pioneer in modern spine surgery, Dr. Cotrel's company Sofamor, was the foundation for what would become Medtronic Spine. Dr. Cotrel's contributions will live on for years to come. Condolences to his family. pic.twitter.com/JJ1Z…

reply retweet favorite
5:27 pm · 02/01/2019 ·
Retweeted by CAPTIS
Twitter
Arab Health
Arab Health
@Arab_Health

The 44th edition of Arab Health is officially now open. #ArabHealth2019 runs until the 31st of January 2019 at the Dubai World Trade Centre and the Conrad Dubai from 10 am to 6 pm. Find out more on our website or download the Arab Health 2019 show app: bit.ly/2n3Z5Q pic.twitter.com/oasI…

reply retweet favorite
5:35 pm · 01/29/2019 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…

reply retweet favorite
6:56 pm · 10/24/2018 ·
Retweeted by CAPTIS
Twitter
Epic CV
Epic CV
@Epic_CV

Read carefully employer's directions on how to apply. #resume #resumetips

reply retweet favorite
7:47 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
World Spine Care
World Spine Care
@WorldSpineCare

Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…

reply retweet favorite
7:46 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Neurochecklists
Neurochecklists
@neurochecklists

Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…

reply retweet favorite
7:40 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…

reply retweet favorite
7:39 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Implantech
Implantech
@Implantech

If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…

reply retweet favorite
7:38 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
American College of Cardiology
American College of Cardiology
@ACCinTouch

Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…

reply retweet favorite
4:46 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

With #CARTcell therapy, an inactive virus programs T cells with new genetic information to help recognize specific antigens found on normal cells and certain blood cancer cells. As the CAR-T cells multiply, new copies also gain this ability. #CARTCellStory pic.twitter.com/Xuoh…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Make plans to visit the Integra LifeSciences Booth# 919 during Plastic Surgery The Meeting September 28th - October 1st. #Integra_LifeSciences #DurableIsBeautiful #PSTM18 #ASPS #PlasticSurgery pic.twitter.com/8QGv…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Fundamental Surgery
Fundamental Surgery
@FundamentalSurg

We are live at #NASS2018 stand 2649. Get hands-on with the world's leading surgical #simulator in #VR with #haptics and experience the future of surgical training. #wearefundamental fundamentalsurgery.c… pic.twitter.com/NgzA…

reply retweet favorite
4:41 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
TRX Orthopedics
TRX Orthopedics
@TRXOrtho

Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1

reply retweet favorite
8:34 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Corin Group
Corin Group
@corintechnology

All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Cardiovascular News
Cardiovascular News
@Cardiovasc_bio

#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO

reply retweet favorite
8:32 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…

reply retweet favorite
8:31 pm · 03/02/2018 ·
Retweeted by CAPTIS
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top